Categories: Uncategorized

Melatonin + CBD = sleep support

Does melatonin work with CBD?

Everything surrounding the world of CBD and medicinal cannabis is astonishing.

In fact, every year more studies and results supporting its properties are revealed.

Melatonin + CBD = sleep support

CBD can promote sleep disruption during the night, while melatonin can promote the onset of sleep. This combination can work to support overall sleep. Interestingly, some individuals may find that CBD makes them more alert without increasing anxiety.

In these individuals, using CBD at night may negatively affect sleep. On the other hand, using it earlier in the day can help with sleep.

This phenomenon is why melatonin, in combination with CBD, used at night and for a short period of time, can address more significant sleep issues, as melatonin can counterbalance the wake-promoting effects of CBD.

What happens with CBD and the sleep process?

Most research on cannabidiol (CBD) has focused on its potential benefits for anxiety disorders, stress, and general feelings of anxiety. This research is relevant to sleep problems, considering that sleep disruption related to stress and anxiety is quite common.

Previous studies examining the use of CBD for sleep have often lacked quality, which may be a contributing factor to the mixed results observed. However, more recent and robust research on the use of CBD for specific sleep issues appears very promising.

At this point, research is pointing more solidly towards CBD as a support for sleep problems related to stress and anxiety. This application is also supported by current evidence indicating that CBD can be beneficial for anxiety-related issues.

Yana Djonua

Recent Posts

Cannabidiol in Neurodevelopment: A Promising Therapy for Autism?

Is Cannabidiol During Neurodevelopment a Promising Therapy for Autism? The question of whether cannabidiol (CBD),…

5 days ago

Exploring Cannabidiol’s Role in Reducing Inflammation-Induced Oxidative Stress

The therapeutic potential of cannabidiol (CBD), a non-psychoactive component of cannabis, has been increasingly recognized…

3 weeks ago

Exploring the Activation of GPR18 by Cannabinoid Compounds

Recent research delves into the pharmacological landscape of GPR18, a G-protein-coupled receptor, and its activation…

3 weeks ago

Cannabidiol: A Potential Therapeutic Agent for Psoriasis

Psoriasis, a chronic skin condition with no definitive cure, affects millions globally, creating a necessity…

1 month ago

Cannabidiol as a Potential Treatment for Anxiety Disorders: Exploring the Evidence

Recent research has brought to light the potential of cannabidiol (CBD), a non-psychoactive component of…

2 months ago

Understanding Id-1’s Role in Glioblastoma Aggressiveness and Potential Therapeutic Strategies

Glioblastoma multiforme (GBM) is the most aggressive and common form of primary brain tumor in…

2 months ago